Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil

被引：31
作者：
Citrome, Leslie [1 ]
机构：
[1] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY 10595 USA
来源：
EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2016年 / 9卷 / 02期
关键词：
intramuscular; depot; Antipsychotic; aripiprazole monohydrate; schizophrenia; long-acting injectable; clinical trials; aripiprazole lauroxil; aripiprazole once-monthly; PLACEBO-CONTROLLED TRIAL; ORAL ANTI-PSYCHOTICS; DOUBLE-BLIND; PALIPERIDONE PALMITATE; HOSPITALIZATION RATES; MAINTENANCE TREATMENT; NON-INFERIORITY; EFFICACY; ANTIPSYCHOTICS; SAFETY;
D O I：
10.1586/17512433.2016.1121809
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aripiprazole monohydrate (AM) and aripiprazole lauroxil (AL) are two different long-acting injectable formulations of aripiprazole. AM 400mg administered once monthly demonstrated efficacy in an acute, double-blind, placebo-controlled, randomized clinical trial, as well as in a double-blind, placebo-controlled, randomized-withdrawal maintenance study, and in two non-inferiority maintenance studies. AL is a prodrug of aripiprazole and available in 441mg, 662mg or 882mg strengths. AL 441mg and 882mg administered once monthly demonstrated efficacy in an acute, double-blind, placebo-controlled, randomized clinical trial. The pharmacokinetic profile of AL also led to approval of dosing intervals of every 6weeks for the 882mg dose. The overall tolerability profiles of both products are consistent with what is known about oral aripiprazole.
引用
收藏
页码：169 / 186
页数：18
相关论文
共 50 条
[11]   A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach [J].
Citrome, Leslie .
CNS DRUGS, 2013, 27 (11) :879-911
[12]   New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia [J].
Citrome, Leslie .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (07) :767-783
[13]   Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications [J].
Citrome, Leslie .
CURRENT DRUG SAFETY, 2009, 4 (03) :229-237
[14]   Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies [J].
Czobor, Pal ;
Van Dorn, Richard A. ;
Citrome, Leslie ;
Kahn, Rene S. ;
Fleischhacker, W. Wolfgang ;
Volavka, Jan .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (08) :1158-1166
[15]   Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis [J].
De Hert, Marc ;
Eramo, Anna ;
Landsberg, Wally ;
Kostic, Dusan ;
Tsai, Lan-Feng ;
Baker, Ross A. .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 :1299-1306
[16]   Effects of aripiprazole once-monthly on domains of personal and social performance: Results from 2 multicenter, randomized, double-blind studies [J].
Fleischhacker, W. Wolfgang ;
Baker, Ross A. ;
Eramo, Anna ;
Sanchez, Raymond ;
Tsai, Lan-Feng ;
Peters-Strickland, Timothy ;
Perry, Pamela P. ;
McQuade, Robert D. ;
Johnson, Brian R. ;
Carson, William H. ;
Kane, John M. .
SCHIZOPHRENIA RESEARCH, 2014, 159 (2-3) :415-420
[17]   Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study [J].
Fleischhacker, W. Wolfgang ;
Sanchez, Raymond ;
Perry, Pamela P. ;
Jin, Na ;
Peters-Strickland, Timothy ;
Johnson, Brian R. ;
Baker, Ross A. ;
Eramo, Anna ;
McQuade, Robert D. ;
Carson, William H. ;
Walling, David ;
Kane, John M. .
BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (02) :135-144
[18]   Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia [J].
Fleischhacker, W. Wolfgang ;
Sanchez, Raymond ;
Johnson, Brian ;
Jin, Na ;
Forbes, Robert A. ;
McQuade, Robert ;
Baker, Ross A. ;
Carson, William ;
Kane, John M. .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (04) :171-176
[19]   Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial [J].
Fleischhacker, W. Wolfgang ;
Heikkinen, Martti E. ;
Olie, Jean-Pierre ;
Landsberg, Wally ;
Dewaele, Patricia ;
McQuade, Robert D. ;
Loze, Jean-Yves ;
Hennicken, Delphine ;
Kerselaers, Wendy .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (08) :1115-1125
[20]   Preparation and Characterization of High-Content Aripiprazole-Loaded Core-Shell Structure Microsphere for Long-Release Injectable Formulation [J].
Hiraoka, Shogo ;
Uchida, Shinya ;
Namiki, Noriyuki .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2014, 62 (07) :654-660
12345